肿瘤患者感染肺炎克雷伯菌常见产酶的检测及耐药性分析*

承德医学院学报 ›› 2018, Vol. 35 ›› Issue (6): 469-472.

肿瘤患者感染肺炎克雷伯菌常见产酶的检测及耐药性分析^*

陈泽城, 邱振华, 周惠娜, 吴红梅

高州市人民医院检验科,广东高州 525200

收稿日期:2018-06-28 出版日期:2018-12-10 发布日期:2021-11-21
基金资助:
* 茂名市科技计划项目（2018303）

DETECTION AND DRUG RESISTANCE ANALYSIS OF COMMON ENZYME PRODUCING STRAINS OF KLEBSIELLA PNEUMONIAE IN TUMOR PATIENTS

CHEN Ze-cheng, QIU Zhen-hua, ZHOU Hui-na, et al

Department of Clinical Laboratory, Gaozhou People's Hospital, Guangdong Gaozhou 525200, China

Received:2018-06-28 Online:2018-12-10 Published:2021-11-21

摘要/Abstract

摘要： 目的: 了解我院肿瘤患者分离的肺炎克雷伯菌产超广谱β-内酰胺酶（ESBLs）和碳青霉烯酶（KPC）的情况,并分析相应菌株对常见抗菌药物的耐药性。方法: 对2017年9月至2018年8月我院恶性肿瘤患者感染的306株肺炎克雷伯菌进行体外药敏试验及产ESBLs和KPC的检测,并对相应菌株的耐药性进行比较分析。结果: 产ESBLs肺炎克雷伯菌检出率高达73.53%（225/306）,产KPC检出率为10.46%（32/306）。产ESBLs菌株对多种抗菌药物的耐药率明显高于非产ESBLs菌株（P<0.05）;产碳青霉烯酶肺炎克雷伯菌（CRKpn）对药敏试验中所有药物均呈高水平耐药,且对大部分药物的耐药率达100.00%。结论: 我院肿瘤患者感染的肺炎克雷伯菌产ESBLs和KPC情况严重,相应菌株耐药率高,必须加强对医院感染的控制,规范抗菌药物的使用,防止产ESBLs菌株及CRKpn进一步增加或扩散。

关键词: 肿瘤患者, 肺炎克雷伯菌, 超广谱β-内酰胺酶, 碳青霉烯酶, 耐药性

Abstract: Objective: To investigate the production of extended-spectrum beta-Lactamases (ESBLs) and carbapenemases (KPC) in Klebsiella pneumoniae isolated from tumor patients, and analyze the drug resistance of corresponding strains to common antibiotics. Methods: The ESBLs and KPC production of 306 strains Klebsiella pneumoniae from tumor patients in our hospital from 2017.9 to 2018.8 were detected, and the drug resistance of corresponding strains to common antibiotics were compared by in vitro drug susceptibility. Results: The detection rate of ESBLs and KPC were 73.53% (225/306) and 10.46% (32/306) respectively. The resistance of ESBLs-producing strains to various antibiotics was significantly higher than that of non-ESBLs-producing strains (P<0.05). The carbapenemase-producing Klebsiella pneumoniae (CRKpn) showed high level of resistance to all the drugs tested, and the resistance rate of most of the drugs reached 100.00%. Conclusions: ESBLs and KPC produced by Klebsiella pneumoniae infected by tumor patients are serious in our hospital, and the drug resistance rate of the corresponding strains is high. It is necessary to strengthen the control of infection, standardize the application of antibiotics, and prevent further increasing or diffusion of ESBLs-producing strains and CRKpn.

Key words: Tumor patients, Klebsiella pneumoniae, Extended-spectrum beta-Lactamases (ESBLs), Carbapenemases (KPC), Drug resistance

中图分类号:

R446.5

陈泽城, 邱振华, 周惠娜, 吴红梅. 肿瘤患者感染肺炎克雷伯菌常见产酶的检测及耐药性分析^*[J]. 承德医学院学报, 2018, 35(6): 469-472.

CHEN Ze-cheng, QIU Zhen-hua, ZHOU Hui-na, et al. DETECTION AND DRUG RESISTANCE ANALYSIS OF COMMON ENZYME PRODUCING STRAINS OF KLEBSIELLA PNEUMONIAE IN TUMOR PATIENTS[J]. Journal of Chengde Medical University, 2018, 35(6): 469-472.

参考文献

[1] 张晓玲,霍丽静,刘鹏,等.秦皇岛市替加环素对耐碳青酶烯类肺炎克雷伯菌体外抗菌活性研究[J].河北医药,2015,37(5):767-769.
[2] 杨青,杜小苹,俞云松,等.5种药敏方法检测产KPC酶肠杆菌科细菌对碳青霉烯类抗生素的耐药性[J].浙江检验医学,2008,6(4):3-6.
[3] 林佩贤,黄宝添,许斐斐,等.重症监护室多重耐药菌医院感染临床特点与耐药性分析[J].国际流行病学传染病学杂志,2015,42(4):228-231.
[4] National Committee for Clinical Laboratory Standards. Performance Standards for antimicrobialsusceptibility testing: M100-S17[S]. Pennsylvania: CLSI, 2009.
[5] 许文,张芹,胡明,等.恶性肿瘤患者感染调查及相关因素分析[J].中华医院感染学杂志,2016,26(11):2526-2528.
[6] 陈艳华,黄玲莎,陆一平,等.肿瘤患者感染产ESBLs大肠埃希氏菌的耐药性及危险因素分析[J].广西医科大学学报,2015,32(2):269-271.
[7] Nordmann P. Trends in beta-lactam resistance among Enterobacteriaceae[J]. Clin Infect Dis, 1998, 27 Suppl 1: S100-106.
[8] 冯雅君,沈萍,杜小幸,等.产碳青霉烯酶KPC-2肺炎克雷伯菌局部流行[J]. 浙江医学,2008,30(9):923-925,930.
[9] Lee CR, Lee JH, Park KS, et al.Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and detection Methods[J]. Front Microbiol, 2016, 7: 895.
[10] Vasoo S, Barreto JN, Tosh PK.Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician[J]. Mayo Clin Procs, 2015, 90(3): 395-403.
[11] 林琳,王晶,肖晓光,等.重症病房耐碳青霉烯肺炎克雷伯菌KPC基因检测及同源性分析[J].国际检验医学杂志,2018,39(7):798-800,804.
[12] 彭乃杰,林哈妮,夏菲,等.碳青霉烯类耐药肺炎克雷伯菌耐药机制和多位点序列分型研究[J].检验医学,2013,28(9):862-863.